Quadruplet Promising in Older Patients With Transplant-Ineligible Multiple Myeloma

By News Health
2 months Ago

(MedPage Today) — TORONTO — A quadruplet regimen elicited favorable outcomes in an older population of transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM), according to phase II trial data.
The study of daratumumab…

Source link : https://www.medpagetoday.com/meetingcoverage/ims/117573

Author :

Publish date : 2025-09-21 20:31:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Pain Patients Often Feel Out of Options. Acupuncture Hides in Plain Sight.

Trump and Republicans Once More Face a Tough Political Fight Over Obamacare

Extinct animals in Prehistoric Planet: Ice Age make it a must-watch

'It sounds dramatic - but singing class saved by life'

Is Chemo Driving Late Cardiac Events in Older Cancer Survivors?

Potassium in Patients with ICDs; mRNA Flu Vaccine; Canceled NIH Funding for Trials